8 Oct 2018
Dr. Gary Allenby, CSO and co-founder of Aurelia Bioscience, a CRO based in Nottingham, UK, discusses how they have been able to apply electrospun micro-scaffold technology to develop 3D cell structures that better imitate physiological conditions for cell-based assays. He highlights how the INTEGRA VIAFLO 384 handheld pipette makes the team's groundbreaking work possible, both in assay development and in screening.